Good afternoon, Mr. Chairman and members of the Committee. It is a pleasure to be here
today as Director of the National Institute of Nursing Research (NINR) to discuss a topic
of importance to all of us how to ensure that the end of our lives is as free of
pain and other symptoms as possible; that this final phase is one of comfort and dignity;
and that our choices of the type and extent of care are respected and implemented.
I am here today before this Committee because the National Institute of Nursing
Research (NINR) is the lead Institute within the National Institutes of Health (NIH) responsible
for coordinating research on palliative care at the end of life. Whether palliative care
research involves conventional or complementary approaches, its purpose is to add
scientifically verified evidence to our base of knowledge about appropriate and
compassionate health care. Research on end of life focuses on clinical management of
physical and psychological symptoms, communication, ethics and clinical decisionmaking,
support of caregivers, and delivery of care. These scientific investigators come from many
disciplines rather than any one discipline and often work in teams. The collaborative goal
of this research is to discover how best to promote quality of life leading to a peaceful
death.
Today I will discuss how end of life issues are receiving increased research and public
policy attention. Recent trends and NIH research responses to these trends will be
summarized, including complementary therapies. And finally, I will identify future
opportunities and challenges.
End-of-life concerns were highlighted in a 1997 report by the Institute of Medicine
(IOM), "Approaching Death: Improving Care at the End of Life." This report
recommended a change of focus when a patient is considered to be in the final phase of
life -- from very aggressive conventional care to one of palliative care, which stresses
comfort and quality of life acceptable to the patient and family members. In addition, the
Robert Wood Johnson Foundation funded the Study to Understand Prognoses and Preferences
for Outcomes and Risks of Treatments (SUPPORT) which also identified some disquieting
facts. Serious pain, common in most terminally ill patients, was undertreated;
discrepancies existed between patient desires and actual treatment; and almost half of
physicians studied were unaware that their patients preferences were "do not
resuscitate." Furthermore, there were many reports from experts that the public was
generally not satisfied with care at the end of life. The IOM stated that while
technological advances in health care "continue to increase life expectancy,
attention to the quality of life and to the inevitable experience of dying has not kept
pace."
National trends point to the need for research in the end-of-life area. The aging and
growth of the population predict an increase in the prevalence of chronic illnesses. More
than 2 million Americans died in 1998, most from chronic illness that they had endured for
a long period of time. More than 70% of deaths occur in those over 65 years of age.
Furthermore, a shift is taking place from patient care in the hospital to family care in
the home, which presents a special challenge for family or friend caregivers. Such
caregivers need help with learning health care delivery skills, problem solving, and use
of community-based services.
The IOM and SUPPORT study results provide a basis for the research being undertaken by
NINR and other researchers. For example, families report that clinicians underestimate
pain levels and other symptoms of patient distress. Families also report distress that
some clinicians view the death of their family member as a failure. Patients report
distress caused by abrupt changes in settings, such as when they are discharged from the
hospital to a nursing home. Patients without health insurance are likely to use expensive
hospitalization for symptoms that could be managed by hospice or home health nurses.
Soon after the IOM report was published, NINR convened a research workshop to address
symptom management and other issues of terminal illness. The meeting, "Symptoms in
Terminal Illness: A Research Workshop," was cosponsored by the National Cancer
Institute (NCI), the National Institute of Allergy and Infectious Diseases (NIAID), the
National Institute of Dental and Craniofacial Research (NIDCR), the National Institute of
Drug Abuse (NIDA), and the then Office of Alternative Medicine (OAM). Palliative care
experts and basic and clinical scientists involved in end of life issues were convened to
assess the state of the science in this area and make recommendations for research. The
workshop focus was on major symptoms of distress, including pain, dyspnea (difficulty
breathing), cognitive disturbances, and cachexia (muscle wasting and weight loss). The
report emphasized the importance of intervening appropriately in the dying process to
maximize quality of life at the very end of life.
Because of NINRs research experience and expertise in the key areas of end of
life and its history of collaborative effort, NINR was designated as the lead to
coordinate NIH research efforts. NINR issued a program announcement, in collaboration with
NCI, NIAID, NIMH (National Institute of Mental Health), and OAM. The request was made to
stimulate integrative, multidisciplinary research programs in basic and clinical areas to
address the constellation of symptoms at the end of life across disease conditions.
Earlier this year NINR initiated a Request for Applications (RFA), which was
cosponsored by seven other NIH components and the Agency for Health Care Policy and
Research (AHCPR). The RFA was issued to generate scientific knowledge leading to improved
care for those at the end of life. Twelve grants resulting from this RFA have just been
funded -- the majority by the NINR. Let me briefly describe some of these new and ongoing
studies.
In the behavioral area, NINR researchers are testing interventions for cancer pain,
such as guided imagery, in which patients imagine, for example, their immune cells
attacking a tumor; cognitive restructuring, where patients can put an unpleasant
experience in a less stressful context; and relaxation techniques. Guided imagery is also
being tested to reduce postoperative pain in children, in combination with analgesia, and
to determine which patients with cancer pain will benefit from this technique. Certain patients may be more receptive than others.
Self care, increasingly important to the public in managing chronic illness, is also
relevant at the end of life. In studying end of life patients with congestive heart
failure and chronic obstructive pulmonary disorder (COPD), researchers are analyzing the
use of acupuncture, massage therapy, vitamins, herbs, and nutritional supplements, in
addition to conventional care.
Technology has both positive and negative effects on end of life. Research is underway
to investigate the use of life support technology, especially mechanical ventilation, in
older individuals. The research study is designed to learn which aspects of maintenance
and withdrawal of life support technology are considered problematic and why. Also under
investigation is how decisions about life-prolonging technologies are influenced by
hospital routines. Another study addresses the positive effects of technology through a
computer intervention called Tele-Care for caregiver spouses of patients at the end of
life. This intervention will be evaluated to ascertain effects on depression, social
support and personal growth of Caucasian and Hispanic caregivers. Information gained from
these studies can help guide us in providing culturally sensitive end of life care.
Models of ethnic and culturally sensitive variations of interventions, such as the one
just mentioned, are needed for health care at the end of life as much as they are at all
other times of life. For example, investigators are studying ethnic differences in African
American and Caucasian approaches to decisionmaking, treatment preferences, and family
caregiver satisfaction with end of life care for their ill family members. The burden and
health of caregivers, as well as their bereavement, are also under study. Decision making,
particularly regarding enhancing quality of life by tailoring health care to
patients wishes, and use of advance directives, is the focus of another newly funded
study being carried out within a managed care environment.
In other ongoing research supported by the NINR, I would like to provide two promising
examples. A study receiving national attention earlier this year was one in which a jaw
relaxation technique and music therapy, separately or together, when combined with the
usual pain medication, significantly reduced pain following major abdominal surgery. This
study was published in the may issue of PAIN. The finding is encouraging because it
is an example of a novel approach to acute pain management. Better management in both
acute and chronic pain that effectively decreases the use of pharmacological agents has
benefits at the end of life.
Distinguishing emotional triggers of dyspnea from physical ones is important in
determining the best treatment for dyspnea at the end of life. NINR-supported research
indicates that patients can differentiate dyspnea caused by distress and anxiety from
dyspnea stemming from physical causes. This distinction will help in the selection of the
most appropriate therapies.
Although NINR funds additional studies that involve either end of life or complementary
therapies, the previous summary provides representative examples. Let me now turn to a
discussion of research in other NIH institutes that addresses the central theme of this
hearing.
The Warren Grant Magnuson Clinical Center
The Clinical Center is responsible for patients enrolled in approximately 900 active
clinical research protocols and offers a wide range of support to meet critical patient
needs. The Clinical Center will soon initiate a clinical program that will provide state of the art pain management, symptom control and palliative care to patients. The program is multidisciplinary and will have active patient and staff education and clinical
research components. A fellowship training program will be developed as the program
matures.
The Department of Rehabilitation Medicine of the Clinical Center provides support for
patients with chronic pain offering a variety of complementary pain alleviation
techniques to reduce the impact of pain and increase functional independence. Examples
include instruction in pain relief strategies, maintenance of a pain journal, and weekly
classes and support group meetings focused on relief of pain. Nonpharmacological
interventions for pain management include massage, exercise and immobilization,
transcutaneous electrical nerve stimulation, imagery and biofeedback. Services also
include acupuncture and acupressure, desensitization, guided imagery, aquatics, relaxation
training and distraction-refocusing.
The Clinical Center also uses a multidisciplinary approach to address the difficult
issues associated with the end of life. Continued participation of patients in research
protocols must be balanced with the needs and wishes of the patient and family members or
significant others. The Social Work Department provides counseling and works with other
disciplines to perform a thorough assessment of the need for palliative care and/or
hospice support. Bereavement counseling is also provided. The Spiritual Ministry
Department establishes spiritually supportive relationships with seriously ill patients
and their families to help them face end of life. Prayer, spiritual discussions and
soothing music are provided, and memorial services are also available.
The Bioethics Department has a portfolio of research projects that address the end of
life. One of these, a study recently published in the New England Journal of Medicine,
reported the results of interviews with 988 terminally ill patients about such issues as
symptoms, physician-patient communication, caregiving needs, and views on euthanasia.
Another study is comparing costs of care at the end of life as they relate to issues such
as managed care versus fee for service; people with different types of terminal illnesses;
and the use or nonuse of hospice care.
The National Cancer Institute
The National Cancer Institute has a dedicated interest in current and planned research
related to palliative, hospice, and end of life care for patients. Studies show that
two-thirds of people with advanced cancer experience significant pain. NCIs
portfolio of pain research is wide-ranging and includes studies that test complementary
strategies.
One example is an NCI-supported study that focuses on resiniferatoxin, an anti-pain
substance isolated from a cactus-like plant, which may lead to the development of new pain
relief drugs. There are also studies of behavioral interventions, such as distraction,
relaxation, and imagery, that may offer care providers with non-pharmacological tools to
help their patients handle pain.
In addition to participating in the program announcement and RFA on management of
symptoms at the end of life, NCI participates in the trans-NIH biobehavioral pain research
program announcement to conduct basic and clinical studies on pain. Some of the activities
included in this announcement that have relevance to this hearing are: examining the role
of the placebo effect in pain treatment; exploring the basic mechanisms of conscious
perception of pain and affective responses; clarifying the relationship between depression
and chronic pain; and determining the effectiveness of biobehavioral pain management in
terminally ill and dying patients.
The National Institute of Neurological Disorders and Stroke
The NINDS supports a broad range of basic and clinical research on pain and is a
participant in the end-of-life RFA. NINDS also shares the lead with NIDCR in the NIH Pain
Research Consortium. Of interest to this Committee is NINDS basic research related
to neurological symptoms that occur in many chronic and terminal disorders. These include
pain, swallowing problems, memory loss, and nausea and vomiting. For example, two recent
basic research findings are unraveling the mysteries of chronic pain states. They involve
separating "good pain," that is, the normal protective sensation, from the
"bad pain" of abnormal chronic pain states. Using animal models, one study
selectively eliminated spinal cord nerve cells that respond to the chemical messenger
substance P. In another study, mice were genetically engineered to omit a form of the
enzyme protein kinase C that is involved in some types of pain signals. In both
experiments, the "good pain" responses were intact, but "bad pain" was
eliminated.
The National Institute on Aging
The National Institute on Aging research portfolio addresses the diverse array of
end-of-life issues affecting the elderly population. Examples of studies include how
staff, family, and residents manage end of life care in nursing homes, and how the stress
of decision making can be reduced during the final phase of life. NIA is also one
of the institute cosponsors of the end-of-life RFA. Through its Alzheimers Disease
Centers program, the NIA-supported researchers at the Boston center have established a
Dementia Study Unit as a clinical model for late-stage Alzheimers disease care, the
first research group in the country to focus efforts on the difficult, emotionally
charged, clinical issues in late-stage and terminal care of this patient population.
Activities have expanded to include an outpatient program, a respite care program, and an
adult day care program. As a result of research in the Dementia Unit, staff developed a
hospice approach to the care of Alzheimers disease patients. This consists of
assigning patients to one of the five levels of care, with progressive limitations on
medical interventions. Treatment limitation decisions are discussed at a meeting of
family members with the Interdisciplinary Treatment Team.
The National Institute of Dental and Craniofacial Research
The National Institute of Dental and Craniofacial Research supports studies that
address key issues at the end of life the prevention and relief of pain. Studies
within the NIDCR portfolio are relevant to palliative, hospice and end of life care
issues, particularly the research on pain. Sharing the lead with NINDS of the trans-NIH
Pain Consortium, NIDCR also operates the Pain Research Clinic in the NIH Clinical Center.
Programs within the clinic include developing better methods for assessing pain,
understanding the mechanisms of acute and chronic pain, and developing new methods of pain
control. Recent findings include an animal model of gene therapy for pain.
The oral complications of cancer therapy are also under study. Radiation treatment
damage to salivary gland tissue and many drug therapies can result in lack of saliva,
or xerostomia, which leads to difficulty in chewing, swallowing, and speaking, problems
for many at the end of life. Research on salivary glands and saliva constitute a
significant component of the NIDCR portfolio. Of note is the development of another animal
model of gene therapy this time to restore saliva production.
The Office of Behavioral and Social Sciences Research, Office of the Director, NIH
The Office of Behavioral and Social Sciences Research (OBSSR), the National Center for
Complementary and Alternative Medicine, and several NIH Institutes, are co-sponsoring a
workshop on October 26-27, 1999 on "Spirituality, Religion, and Health." An
expert panel will review the state of the science in the area, and assist in developing a
research agenda relevant to NIH. Numerous issues will be addressed, including linkages to
morbidity and mortality, biobehavioral and psychosocial mechanisms, social and cultural
influences, measurement issues, gaps in the literature, and scientific opportunities. A
report summarizing the work of the invited panel will be disseminated following the
workshop.
National Center for Complementary and Alternative Medicine
The National Center for Complementary and Alternative Medicine (NCCAM), a new entity,
is the successor organization of the OAM, with enhanced statutory authority and function,
and increased staffing levels. Many of NCCAMs studies concern palliative care
research, with a focus on increasing patient comfort, diminishing pain, and rendering
disease symptoms less intense or severe. Although NCCAM does not have a specific focus on
end of life, research results of many studies may be beneficial to patients at this final
phase. Among these projects are an examination of the benefits of hatha yoga on the
cognitive and behavioral changes associated with aging and neurological disorders;
evaluation of the effects of acupuncture on persistent pain and inflammation; a clinical
study of St. Johns Worts effects on major depression; the effect of
acupuncture and moxibustion (heat applied at the acupuncture point), and, in collaboration
with NIA, the efficacy of ginkgo biloba (a botanical product) in older individuals who are
at risk for dementia, which may have pertinence to those at the end of life.
As is evident, the NIH institutes are actively pursuing many avenues of research, both
conventional and complementary, of relevance to patients and families at the end of life.
Trans-NIH Committees relevant to coordination of these efforts include the trans-NIH Pain
Consortium, the trans-NIH Alzheimers Working Group, and other formal and informal
Committees.
In conclusion, it is becoming increasingly clear that, as we look to the future,
distressing symptoms considered inevitable at the end of life can be eased, and that more
can be done to maintain a patients quality of life, sense of control, and dignity. A
number of issues remain to be resolved, however, through research. Our aging population
depends on the health care system and the evolution of how it manages end-of-life care. We
need to know more about the appropriate course of treatment during the dying process.
Despite the availability of pain medications for terminally ill patients, pain is still
inadequately treated. We need improved assessment tools to help health care professionals
accurately evaluate symptoms at the end of life. Patients comfort needs and their
wishes for end of life care must be respected. Family caregivers needs must be
addressed so that they become competent in providing pharmacological and other treatments,
determining the changing nutritional needs of a dying person, and responding to changes in
function and care required by those changes. Caregivers need assistance in coping with
stress and maintaining their own health.
Complementary and conventional therapies have the potential to provide important
information and new therapeutic approaches for improving care and quality of life at the
end of life. With sufficient emphasis and resources, end of life issues and needs can
be resolved by the health care research and practice communities. NINR is pleased to have
a central role in addressing how we might best achieve these results. Thank you, Mr.
Chairman. I will be happy to answer any questions.